Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes

被引：0
|
作者：
Bunck, M. C. [1 ]
Corner, A. [2 ]
Diamant, M. [1 ]
Eliasson, B. [3 ]
Malloy, J. L. [4 ]
Shaginian, R. M. [5 ]
Deng, W. [4 ]
Kendall, D. M. [4 ]
Smith, U. [3 ]
Yki-Jarvinen, H. [2 ]
Heine, R. J. [1 ]
Taskinen, M. R. [2 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, Dept Endocrinol, Amsterdam, Netherlands
[2] Helsinki Univ Hosp, Dept Med, Helsinki, Finland
[3] Sahlgrens Univ Hosp, Lundberg Lab Diabet Res, Gothenburg, Sweden
[4] Amylin Pharmaceut Inc, San Diego, CA USA
[5] Eli Lilly & Co, Nederland, Houten, Netherlands
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
879
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [31] Discontinuation of metformin in type 2 diabetes patients treated with insulin
    Wulffelé, MG
    Kooy, A
    Lehert, P
    Bets, D
    Oom, JA
    van der Burg, BB
    Donker, AJM
    Stehouwer, CDA
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (06): : 249 - 252
  • [32] Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus
    Pattanaik, S. R.
    Shah, Parag
    Baker, Abu
    Sinha, Navin
    Kumar, Neeraj
    Swami, Onkar C.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (04) : OE8 - OE12
  • [33] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
    Bailey, C. J.
    Gross, J. L.
    Bastone, L.
    Bastien, A.
    List, J. F.
    DIABETOLOGIA, 2009, 52 : S76 - S76
  • [34] The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus
    Shaw, JTE
    Purdie, DM
    Neil, HAW
    Levy, JC
    Turner, RC
    DIABETOLOGIA, 1999, 42 (01) : 24 - 27
  • [35] Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus
    D. Giugliano
    A. Ceriello
    E. Razzoli
    K. Esposito
    Clinical Drug Investigation, 2008, 28 : 199 - 210
  • [36] Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus
    Giugliano, D.
    Ceriello, A.
    Razzoli, E.
    Esposito, K.
    CLINICAL DRUG INVESTIGATION, 2008, 28 (04) : 199 - 210
  • [37] Safety of Exenatide Once Weekly in Patients with Type 2 Diabetes Treated with a Thiazolidinedione
    Norwood, Paul
    Pintilei, Ella
    Pop, Lavinia
    Liutkus, Joanne
    Choi, Suktae
    Giaconia, Joseph
    Trautman, Michael
    DIABETES, 2010, 59 : A195 - A195
  • [38] Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
    Liu, Jia
    Hu, Yanjin
    Xu, Yuan
    Jia, Yumei
    Miao, Li
    Wang, Guang
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [39] Exenatide: A guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus
    不详
    Drugs & Therapy Perspectives, 2007, 23 (10) : 5 - 8
  • [40] Exenatide - A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea)
    Cvetkovic, Risto S.
    Plosker, Greg L.
    DRUGS, 2007, 67 (06) : 935 - 954
12345